STOCK TITAN

Rocket Doctor Inc. Selected to Speak at Google Accelerator Alumni Event and Present at Demo Day for Heal.LA Accelerator

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Rocket Doctor AI (OTC: AIRDF) announced that CEO Dr. Bill Cherniak spoke at the Google Accelerator Alumni Summit in Mexico City and presented at Heal.LA Accelerator Demo Day on Nov 26, 2025. As the only healthcare founder invited to speak, he discussed Rocket Doctor’s journey and the company's use of Google Gemini conversational models in its AI Nurse platform. Rocket Doctor AI says it is exploring expanded capabilities after the recent Gemini 3.0 launch and highlighted ongoing integration with Google Cloud and its proprietary Global Library of Medicine (GLM). The company remains focused on scaling clinically aligned AI tools and access to care into 2026.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – AIRDF

+9.63%
1 alert
+9.63% News Effect

On the day this news was published, AIRDF gained 9.63%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Panel founders: 3 other founders Founder feedback group: 15 other founders Gemini version: Gemini 3.0 +4 more
7 metrics
Panel founders 3 other founders Google Accelerator Alumni Event panel size
Founder feedback group 15 other founders Closed-door product feedback session with Google teams
Gemini version Gemini 3.0 Latest Google AI model powering AI Nurse expansion plans
Heal.LA audience more than 100 healthcare professionals Heal.LA Accelerator Demo Day presentation reach
Heal.LA duration 9-month Accelerator Length of Heal.LA program completed by Rocket Doctor
Invited founders half a dozen founders Number of founders asked to speak at Google event
Roadmap horizon 2026 Innovation roadmap timeframe mentioned by the company

Market Reality Check

Price: $0.4704 Vol: Volume 31,256 is at 33% o...
low vol
$0.4704 Last Close
Volume Volume 31,256 is at 33% of the 93,764 share 20-day average, indicating muted trading interest pre-announcement. low
Technical Price at 0.57455 is trading above the 200-day MA of 0.55, showing a modestly constructive longer-term trend.

Peers on Argus

No peers or sector momentum flags were detected, suggesting this AI and digital ...

No peers or sector momentum flags were detected, suggesting this AI and digital health visibility news is being evaluated on a stock-specific basis.

Historical Context

5 past events · Latest: Dec 08 (Positive)
Pattern 5 events
Date Event Sentiment Move Catalyst
Dec 08 AI pilot partnership Positive -5.7% Announced AI-powered clinical decision support pilot across Alberta primary care sites.
Dec 05 CFO change & awards Neutral -5.7% Announced interim CFO appointment and new stock option and RSU grants to stakeholders.
Dec 04 Education partnership Positive +2.0% Formed strategic partnership with Toronto Metropolitan University for digital clinical education.
Dec 02 Earnings & growth update Positive +1.2% Reported Q3 2025 revenue growth, high gross margin, cash increase and U.S. expansion milestones.
Nov 26 Ecosystem recognition Positive +9.6% CEO spoke at Google Accelerator Summit and Heal.LA Demo Day on AI Nurse and Gemini 3.0.
Pattern Detected

Recent AI, partnership, and growth updates have generally seen positive price alignment, with one notable divergence on an AI pilot announcement.

Recent Company History

Over late 2025, Rocket Doctor AI reported Q3 2025 revenue of $529,123 with strong gross margins and financing support, plus U.S. payer contracts and an NIH SBIR award. The company added an education partnership with Toronto Metropolitan University and announced management changes with new RSU and option grants. An AI pilot in Alberta and the Google Accelerator/Heal.LA appearances highlighted its AI Nurse platform and Gemini 3.0 integration. Today’s announcement extends this trajectory of AI-focused partnerships and ecosystem validation.

Market Pulse Summary

The stock moved +9.6% in the session following this news. A strong positive reaction aligns with pri...
Analysis

The stock moved +9.6% in the session following this news. A strong positive reaction aligns with prior responses to ecosystem and AI milestones, such as the 9.63% move on the same Google/Heal.LA news and gains after the Q3 2025 update. The market has often rewarded validation of the AI Nurse platform and new partnerships. However, past financing activity and a history of at least one negative move on AI news suggest that enthusiasm could fade if execution, revenue growth, or capital needs later disappoint.

Key Terms

conversational AI, electronic medical record, federally qualified health centers (FQHCs), Google Cloud, +1 more
5 terms
conversational AI technical
"AI Nurse platform utilizes Google Gemini for conversational AI"
Conversational AI is technology that allows computers to understand, process, and respond to human language in a way that feels natural and interactive, similar to chatting with a person. It enables machines to hold conversations, answer questions, and assist with tasks automatically. For investors, it matters because this technology can improve customer service, streamline operations, and create new opportunities across many industries.
electronic medical record medical
"embedded within their AI-enabled electronic medical record and sophisticated patient care"
An electronic medical record is a digital version of a patient’s chart that stores clinical notes, test results, prescriptions and treatment history in a secure, searchable system—like a locked, organized digital filing cabinet for a doctor’s office or hospital. Investors care because EMR systems drive recurring software and services revenue, affect healthcare providers’ efficiency and costs, and carry regulatory, cybersecurity and interoperability risks that can influence a company’s profitability and valuation.
federally qualified health centers (FQHCs) medical
"health systems, federally qualified health centers (FQHCs) and otherwise"
Federally qualified health centers (FQHCs) are nonprofit or public primary care clinics that receive federal grants and enhanced Medicare/Medicaid payments to provide comprehensive medical, dental and mental health services to underserved communities, often on a sliding-fee scale. For investors, FQHCs matter because their federal funding and steady patient base can create more predictable revenue streams, but they also face policy, reimbursement and regulatory risks that affect financial performance.
Google Cloud technical
"Global Library of Medicine (GLM), and our digital health platform and marketplace, are built on Google Cloud"
Google Cloud is a suite of online computing services and storage offered by a major technology provider, letting businesses rent powerful computers, data storage, and tools over the internet instead of owning and running their own hardware. For investors, it matters because cloud services are a growing, recurring source of revenue that can reflect a company’s ability to attract and retain customers, scale efficiently, and compete in data-driven markets—similar to how a utility’s steady customer base signals reliable income.
clinical innovation medical
"Gemini 3.0 as a pivotal moment for accelerating clinical innovation"
Clinical innovation is the development and adoption of new medical treatments, devices, diagnostic tests, procedures or ways of delivering care that are tested and used in patients. For investors it matters because successful clinical innovations can create new revenue streams, competitive edge or lower costs if they prove safer, more effective or cheaper—like a better engine making a car more desirable—while failures, regulatory hurdles and reimbursement issues create significant financial risk.

AI-generated analysis. Not financial advice.

  • Rocket Doctor Inc. CEO Dr. Bill Cherniak was invited to speak at the Google Accelerator Alumni Event in Mexico City, joining a panel of 3 other founders in front of an audience of hundreds of Google Accelerator Alumni.
  • As the only healthcare company selected to speak, Dr. Cherniak shared Rocket Doctor’s journey and insights on deploying responsible, accessible AI in healthcare, eventually being acquired by Treatment.com AI, now Rocket Doctor AI.
  • At the event were several of Google’s top leaders in artificial intelligence products and engineering. Rocket Doctor was also selected to join a small group of 15 other founders to give specific product feedback and discuss new opportunities in a closed-door session.
  • Rocket Doctor’s AI Nurse platform utilizes Google Gemini for conversational AI, and the company is exploring expanded opportunities following the launch of Gemini 3.0 last week.
  • While in Mexico City, Dr. Cherniak also presented virtually for the Larta Institute's Heal.LA Accelerator Demo Day, speaking to an audience of more than 100 healthcare professionals from across Southern California in health insurance plans, State Government, hospitals, health systems, federally qualified health centers (FQHCs) and otherwise.

Vancouver, BC, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc.'s (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) wholly-owned digital health platform and marketplace Rocket Doctor Inc. (“Rocket Doctor”) is proud to announce that co-founder and CEO, Dr. Bill Cherniak, was invited to participate in the annual Google Accelerator Alumni Summit in Mexico City last week, joining senior Google leaders and fellow founders to help inform the company’s future product roadmap.

During the summit, Dr. Cherniak served as a panelist, sharing Rocket Doctor’s journey and offering insights on deploying responsible, accessible AI in healthcare. He met with Google teams, including senior leaders from Google DeepMind and engineering, to discuss product planning, roadmap development, and next-generation platform capabilities. These talks provided insight into how advanced models, including Google’s newly launched Gemini 3.0 update, can enhance the Rocket Doctor experience for patients and clinicians.

Rocket Doctor AI’s “AI Nurse" platform is currently leveraging Google Gemini models for its conversational AI, and the company is now exploring expanded opportunities following the Gemini 3.0 launch. 

Just as the event was concluding, Dr. Cherniak joined the other Heal.LA Fellows for their Demo Day presentations, graduating from their 9-month Accelerator. He spoke to the innovative approaches Rocket Doctor is taking to increasing access to care for millions of patients across California, empowering physician autonomy and access to care embedded within their AI-enabled electronic medical record and sophisticated patient care coordination system.

“It is an incredible honor to be a part of the Google Accelerator ecosystem, which contains only a select number of founders from around the world. More than that, to be one of only half a dozen founders asked to speak at the event about what we built at Rocket Doctor, and how we journeyed to becoming a publicly-traded company under Treatment.com AI, now Rocket Doctor AI, was an incredible moment. Being at the event also gave us direct access to some of the senior leadership and engineering teams at Google, which will be invaluable to our growth and success,” said Dr. Bill Cherniak, CEO of Rocket Doctor Inc.

“Collaborating directly with the people shaping the future of advanced AI models allows us to accelerate Rocket Doctor AI’s mission: delivering accessible, high-quality care to patients everywhere, including rural and remote communities where support is critically needed.”

As Rocket Doctor AI continues to advance its AI Nurse platform, the company sees the launch of Google’s Gemini 3.0 as a pivotal moment for accelerating clinical innovation. Reflecting on the opportunity, Dr. Essam Hamza, CEO of Rocket Doctor AI noted “Both Rocket Doctor AI’s proprietary Global Library of Medicine (GLM), and our digital health platform and marketplace, are built on Google Cloud. The new capabilities unlocked by Gemini 3.0 allow us to move faster and build smarter. These advancements open the door for more intuitive, clinically aligned AI tools that support both doctors and patients.”

Looking ahead, Rocket Doctor AI is committed to driving patient-centered, clinically sound AI solutions. By leveraging foundational models and other advanced tools, the company will continue to strengthen access to care as part of its innovation roadmap into 2026.

About Rocket Doctor AI Inc.

Rocket Doctor AI Inc. delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company’s proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide.

Alongside the GLM is Rocket Doctor Inc, and its AI-powered digital health platform and marketplace. Having helped empower over 300 MDs to provide care to more than 700,000 patient visits, our proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices - improving efficiency, restoring autonomy to MDs, and expanding patient access to care.

By reducing administrative burdens and ensuring greater consistency in care, our technology creates more time for meaningful physician-patient interactions. We are committed to reaching underserved, rural, and remote communities in Canada who often lack access to family doctors and supporting patients on Medicaid and Medicare in the United States. With advanced AI, large language models, and connected medical devices, Rocket Doctor AI is redefining modern healthcare - making it more scalable, equitable, and patient-centered.

To learn more about Rocket Doctor AI Inc’s products and services, contact:

www.rocketdoctor.ai  or email: info@rocketdoctor.ai


FOR ADDITIONAL INFORMATION, CONTACT:

Dr. Essam Hamza, CEO, Rocket Doctor AI
essam.hamza@rocketdoctor.ai

Dr. Bill Cherniak, CEO, Rocket Doctor Inc.
bill@rocketdoctor.io


For media inquiries, contact: media@rocketdoctor.ai
Call: +1 (778) 819 8321

Cautionary Statements

This news release contains forward-looking statements relating to the future operations of Rocket Doctor AI Inc. and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the Offering, the use of proceeds of the Offering, the filing of a Prospectus Supplement and future plans and objectives of Rocket Doctor AI Inc., are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Rocket Doctor AI Inc.'s expectations include other risks detailed from time to time in the filings made by Rocket Doctor AI Inc. with securities regulators.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Rocket Doctor AI Inc. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Rocket Doctor AI Inc. will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.



 

FAQ

Why did Rocket Doctor AI (AIRDF) CEO speak at the Google Accelerator Alumni Summit on Nov 26, 2025?

Dr. Bill Cherniak was invited to share Rocket Doctor’s experience deploying responsible AI in healthcare and to discuss product roadmap input with Google leaders.

How does Rocket Doctor AI (AIRDF) use Google Gemini and what changed with Gemini 3.0?

Rocket Doctor’s AI Nurse platform leverages Google Gemini conversational models and the company says Gemini 3.0 unlocks expanded capabilities for clinician‑aligned tools.

What was Rocket Doctor AI’s (AIRDF) involvement in Heal.LA Accelerator Demo Day?

Dr. Cherniak presented virtually at Demo Day after graduating the 9‑month Heal.LA program, addressing more than 100 Southern California healthcare stakeholders.

Does Rocket Doctor AI (AIRDF) run its platform on Google Cloud?

Yes; the company states its digital health platform and its Global Library of Medicine are built on Google Cloud.

What near‑term goals did Rocket Doctor AI (AIRDF) highlight after the events?

The company emphasized accelerating clinically aligned AI tools, expanding patient access, and advancing its roadmap into 2026.

Will Rocket Doctor AI’s (AIRDF) participation with Google influence product development?

Rocket Doctor says meetings with Google DeepMind and engineering informed roadmap planning and may help shape next‑generation platform capabilities.
Rocket Doctor AI

OTC:AIRDF

View AIRDF Stock Overview

AIRDF Rankings

AIRDF Latest News

AIRDF Stock Data

42.44M
89.48M
Health Information Services
Healthcare
Link
Canada
Vancouver